Publicacions en col·laboració amb investigadors/es de Hospital de Fuenlabrada (8)

2023

  1. Novel Approaches in the Systemic Management of High-Risk Prostate Cancer

    Clinical Genitourinary Cancer, Vol. 21, Núm. 6, pp. e485-e494

2021

  1. Extreme hypofractionation with sbrt in localized prostate cancer

    Current Oncology, Vol. 28, Núm. 4, pp. 2933-2949

  2. Management of resectable stage iii-n2 non-small-cell lung cancer (Nsclc) in the age of immunotherapy

    Cancers, Vol. 13, Núm. 19

2020

  1. High-dose neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery in potentially-resectable stage IIIA-N2 NSCLC. A multi-institutional retrospective study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

    Reports of Practical Oncology and Radiotherapy, Vol. 25, Núm. 3, pp. 447-455

2019

  1. Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

    Clinical and Translational Oncology, Vol. 21, Núm. 6, pp. 735-744

2018

  1. Importance of 68Ga-PSMA PET/CT in hospital practice. View of the radiation oncologist

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 5, pp. 302-314

  2. Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society)

    Lung Cancer, Vol. 118, pp. 119-127

2017

  1. Magnetic resonance imaging for prostate cancer before radical and salvage radiotherapy: What radiation oncologists need to know

    World Journal of Clinical Oncology, Vol. 8, Núm. 4, pp. 305-319